Dr. Stephen Jones, DO
NPI: 1346555455
Total Payments
$118,526
2024 Payments
$61,130
Companies
14
Transactions
143
Medicare Patients
3,606
Medicare Billing
$441,543
Payment Breakdown by Category
Consulting$116,050 (97.9%)
Food & Beverage$2,452 (2.1%)
Education$24.26 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $116,050 | 70 | 97.9% |
| Food and Beverage | $2,452 | 72 | 2.1% |
| Education | $24.26 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kedplasma LLC | $116,050 | 70 | $0 (2024) |
| Horizon Therapeutics plc | $779.45 | 20 | $0 (2023) |
| ABBVIE INC. | $504.19 | 15 | $0 (2023) |
| Alcon Vision LLC | $480.20 | 15 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $142.35 | 3 | $0 (2020) |
| Glaukos Corporation | $122.29 | 3 | $0 (2021) |
| Microsurgical Technology, Inc. | $112.44 | 1 | $0 (2024) |
| Shire North American Group Inc | $88.88 | 6 | $0 (2018) |
| Boston Scientific Corporation | $66.67 | 1 | $0 (2020) |
| Allergan, Inc. | $64.19 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61,130 | 26 | Kedplasma LLC ($60,848) |
| 2023 | $34,657 | 50 | Kedplasma LLC ($33,721) |
| 2022 | $21,933 | 41 | Kedplasma LLC ($21,481) |
| 2021 | $414.92 | 11 | Horizon Therapeutics plc ($270.69) |
| 2020 | $130.04 | 4 | Boston Scientific Corporation ($66.67) |
| 2019 | $141.22 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($119.48) |
| 2018 | $47.23 | 3 | Shire North American Group Inc ($47.23) |
| 2017 | $73.79 | 5 | Shire North American Group Inc ($41.65) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,501.75 | General |
| 12/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,398.25 | General |
| 11/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,501.75 | General |
| 11/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,398.25 | General |
| 11/19/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,501.75 | General |
| 10/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,398.25 | General |
| 10/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,501.75 | General |
| 09/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,398.25 | General |
| 08/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,501.75 | General |
| 08/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,398.25 | General |
| 08/07/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,501.75 | General |
| 07/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,398.25 | General |
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/28/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 05/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 04/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 04/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 03/08/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Ophthalmology | ||||||
| 02/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 01/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $2,448.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,221 | 1,439 | $337,148 | $150,225 |
| 2022 | 17 | 882 | 999 | $231,273 | $108,300 |
| 2021 | 17 | 800 | 937 | $210,930 | $108,238 |
| 2020 | 16 | 703 | 774 | $169,342 | $74,781 |
Total Patients
3,606
Total Services
4,149
Medicare Billing
$441,543
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 54 | 54 | $56,000 | $34,069 | 60.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 54 | 81 | $89,100 | $33,328 | 37.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 294 | 413 | $54,516 | $25,915 | 47.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 163 | 170 | $31,790 | $14,685 | 46.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 110 | 110 | $24,420 | $11,056 | 45.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 25 | 38 | $17,518 | $8,792 | 50.2% |
| 92134 | Imaging of retina | Office | 2023 | 156 | 162 | $10,530 | $4,689 | 44.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 77 | 77 | $9,779 | $4,401 | 45.0% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 25 | 28 | $5,320 | $3,425 | 64.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 66 | 103 | $20,600 | $2,845 | 13.8% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 107 | 108 | $7,344 | $2,462 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $3,973 | $1,652 | 41.6% |
| 11440 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 11 | 12 | $1,968 | $1,258 | 63.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 39 | 41 | $2,665 | $1,077 | 40.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 13 | $1,625 | $570.24 | 35.1% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 44 | 44 | $44,000 | $27,912 | 63.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 29 | 47 | $51,700 | $19,390 | 37.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 218 | 280 | $36,960 | $16,960 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 74 | $14,430 | $6,256 | 43.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 17 | 24 | $11,064 | $5,783 | 52.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 45 | 45 | $8,415 | $4,147 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 62 | $8,494 | $4,045 | 47.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $9,144 | $3,689 | 40.3% |
| 92134 | Imaging of retina | Office | 2022 | 102 | 110 | $7,150 | $3,189 | 44.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 28 | 28 | $6,216 | $2,856 | 46.0% |
About Dr. Stephen Jones, DO
Dr. Stephen Jones, DO is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1346555455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Jones, DO has received a total of $118,526 in payments from pharmaceutical and medical device companies, with $61,130 received in 2024. These payments were reported across 143 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($116,050).
As a Medicare-enrolled provider, Jones has provided services to 3,606 Medicare beneficiaries, totaling 4,149 services with total Medicare billing of $441,543. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Other Specialties Ophthalmology
- Location Pensacola, FL
- Active Since 08/12/2010
- Last Updated 10/25/2021
- Taxonomy Code 207WX0200X
- Entity Type Individual
- NPI Number 1346555455
Products in Payments
- TEPEZZA (Drug) $779.45
- Clareon (Device) $418.90
- LUMIGAN (Drug) $238.36
- VUITY (Drug) $154.73
- DURYSTA (Drug) $111.10
- VYZULTA (Drug) $96.37
- XIIDRA (Drug) $88.88
- KXL System (Device) $80.26
- SUPERION (Device) $66.67
- RESTASIS MULTIDOSE (Drug) $64.19
- TEPEZZA (Biological) $63.64
- ENVISTA (Device) $45.98
- Vabysmo (Drug) $21.99
- iStent inject Trabecular Micro-Bypass Stent System (Device) $21.74
- Rocklatan (Drug) $20.80
- AcrySof IQ PanOptix (Device) $20.50
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $20.29
- ORA (Device) $20.00
- OXERVATE (Drug) $17.70
- BESIVANCE (Drug) $11.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.